Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Therapeutic Drug Monitoring
25%
Malignant Neoplasm
17%
Pharmacodynamics
16%
Cyclophosphamide
14%
HIV
13%
Anticarcinogen
13%
Carboplatin
13%
Chemotherapy
12%
Docetaxel
12%
Thiotepa
11%
Paclitaxel
11%
Ritonavir
10%
Solid Malignant Neoplasm
10%
Neoplasm
10%
Non Small Cell Lung Cancer
9%
Breast Cancer
8%
Nevirapine
8%
Sunitinib
7%
Pazopanib
7%
Monoclonal Antibody
7%
Cmin
6%
Clinical Trial
6%
Adverse Event
6%
Capecitabine
6%
Active Metabolite
5%
High Dose Chemotherapy
5%
Cisplatin
5%
CYP3A4
5%
Biological Marker
5%
Efavirenz
5%
Gemcitabine
5%
Imatinib
5%
Drug-Drug Interaction
5%
Pharmacokinetic Modeling
5%
Indisulam
5%
High Performance Liquid Chromatography
5%
Neutropenia
5%
Elimination
5%
Castration Resistant Prostate Cancer
5%
Keyphrases
Pharmacokinetics
50%
Therapeutic Drug Monitoring
22%
Population Pharmacokinetics
21%
Plasma Concentration
15%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
15%
Human Plasma
13%
Cyclophosphamide
13%
Carboplatin
12%
Ritonavir
11%
Thiotepa
11%
Docetaxel
10%
Paclitaxel
9%
Nevirapine
8%
Pharmacokinetic Study
7%
Oncology
7%
Cancer Patients
7%
Pazopanib
6%
Population Pharmacokinetic Model
6%
HIV Patients
6%
Clinical Pharmacology
6%
Pharmacodynamics
6%
Monoclonal Antibody
6%
Active Metabolite
6%
Confidence Interval
6%
Capecitabine
6%
Sunitinib
6%
Efavirenz
6%
High-dose Chemotherapy
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
5%
Pharmacokinetic Analysis
5%
Cmin
5%
Antiviral Drugs
5%
Gemcitabine
5%
Protease Inhibitors
5%
Drug Interactions
5%
Solid Tumors
5%
Indisulam
5%
Population Pharmacokinetic Analysis
5%
